Primary central nervous system lymphomas in immunocompromised patients require specific response criteria
Nina Schulz1, Lucia Nichelli2, Laurence Schenone3,4
1Department of Neurooncology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Sorbonne Université, Inserm, CNRS, UMR S 1127, ICM, IHU, Paris, France. nina.u.schulz@gmail.com.
Insights
Immunosuppression increases risk for primary central nervous system lymphomas (PCNSL). Alarming MRI findings post-treatment in these patients are common but not predictive of poor outcomes, suggesting adapted response criteria are needed.
Area of Science:
- Neuro-oncology
- Radiology
- Immunology
Background:
- Primary central nervous system lymphomas (PCNSL) are associated with immunosuppression.
- Immunocompromised patients with PCNSL exhibit distinct radiological features.
- Current MRI response criteria may not accurately assess PCNSL in this population.
Purpose of the Study:
- To describe the radiological evolution of treated PCNSL in immunocompromised patients.
- To propose adapted MRI response criteria for immunocompromised individuals with PCNSL.
Main Methods:
- Multicenter retrospective study.
- Inclusion of adult immunocompromised patients with newly diagnosed PCNSL.
- Evaluation of MRI data at baseline, intermediate, end-of-treatment, and follow-up.
Main Results:
- At baseline, most PCNSL lesions were necrotic and some hemorrhagic.
- Post-treatment, many patients showed persistent contrast enhancement and large necrotic lesions.
- These concerning radiological features were not associated with poorer outcomes and diminished over time.
Conclusions:
- End-of-treatment MRI in immunocompromised patients with PCNSL may show alarming features like persistent enhancement.
- These findings are often linked to lesion necrosis and hemorrhage, not necessarily a worse prognosis.
- Adapted MRI response criteria are proposed for this specific patient group.
Purpose:
Immunosuppression is a well-established risk factor for primary central nervous system lymphomas (PCNSLs), which present in this context distinct radiological characteristics. Our aim was to describe the radiological evolution of treated PCNSL in immunocompromised patients and suggest adapted MRI response criteria.
Methods:
We conducted a multicenter retrospective study of patients from the French LOC, K-Virogref and CANCERVIH network databases and enrolled adult immunocompromised patients with newly diagnosed PCNSL.
Results:
We evaluated the baseline, intermediate, end-of-treatment and follow-up MRI data of 31 patients (9 living with HIV, 16 with solid organ transplantation and 6 with an autoimmune disease under chronic immunosuppressive therapy). At baseline, 23/30 (77%) patients had necrotic lesions with ring enhancement and 28% of the lesions were hemorrhagic. At the end of the first-line treatment, 12/28 (43%) patients could not be classified according to the IPCG criteria. Thirteen of 28 (46%) patients still harbored contrast enhancement, and 11/28 (39%) patients had persistent large necrotic lesions with a median diameter of 15 mm. These aspects were not associated with a pejorative outcome and progressively diminished during follow-up. Six patients relapsed; however, we failed to identify any neuroimaging risk factors on the end-of-treatment MRI.
Conclusion:
In immunocompromised patients, PCNSLs often harbor alarming features on end-of-treatment MRI, with persistent contrast-enhanced lesions frequently observed. However, these aspects seemed to be related to the necrotic and hemorrhagic nature of the lesions and were not predictive of a pejorative outcome. Specific response criteria for this population are thereby proposed.
More Related Videos
14:04Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
08:01Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Related Concept Videos
Cells of the Adaptive Immune Response
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Cell-mediated Immune Responses
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
